On April 1 Minister Selby announced the addition of six new cancer drugs to the Manitoba Formulary and the Manitoba Home Cancer Drug Program. Coverage for these drugs will begin on April 16, 2014. [CancerCare
Manitoba news item]
“The new drugs include:
Inlyta and Votrient for the treatment of renal cancer;
Iressa for the treatment of lung cancer;
Sutent for the treatment of pancreatic tumours;
Jakavi for the treatment of myelofibrosis, a bone marrow disorder; and
Xtandi and Zytiga for the treatment of prostate cancer.”
Here is a selection of papers, websites and a video on breast health for Manitoba teens that might interest you. [link]